Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Sep 19;12(9):e062088.
doi: 10.1136/bmjopen-2022-062088.

Study protocol of REpeat versus SIngle ShoT Antibiotic prophylaxis in major Abdominal Surgery (RESISTAAS I): a prospective observational study of antibiotic prophylaxis practice for patients undergoing major abdominal surgery

Affiliations
Observational Study

Study protocol of REpeat versus SIngle ShoT Antibiotic prophylaxis in major Abdominal Surgery (RESISTAAS I): a prospective observational study of antibiotic prophylaxis practice for patients undergoing major abdominal surgery

Anastasia Murtha-Lemekhova et al. BMJ Open. .

Abstract

Introduction: Surgical site infections (SSIs) are among the most common complications after abdominal surgery and develop in approximately 20% of patients. These patients suffer a 12% increase in mortality, underlying the need for strategies reducing SSI. Perioperative antibiotic prophylaxis is paramount for SSI prevention in major abdominal surgery. Yet, intraoperative redosing criteria are subjective and whether patients benefit from it remains unclear.

Methods and analysis: The REpeat versus SIngle ShoT Antibiotic prophylaxis in major Abdominal Surgery (RESISTAAS I) study is a single-centre, prospective, observational study investigating redosing of antibiotic prophylaxis in 300 patients undergoing major abdominal surgery. Adult patients scheduled for major abdominal surgery will be included. Current practice of redosing regarding number and time period will be recorded. Postoperative SSIs, nosocomial infections, clinically relevant infection-associated bacteria, postoperative antibiotic treatment, in addition to other clinical, pharmacological and economical outcomes will be evaluated. Differences between groups will be analysed with analysis of covariance.

Ethics and dissemination: RESISTAAS I will be conducted in accordance with the Declaration of Helsinki and internal, national and international standards of GCP. The Medical Ethics Review Board of Heidelberg University has approved the study prior to initiation (S-404/2021). The study has been registered on 7 February 2022 at German Clinical Trials Register, with identifier DRKS00027892. We plan to disseminate the results of the study in a peer-reviewed journal.

Trial registration: German Clinical Trials Register (DRKS): DRKS00027892.

Keywords: adult surgery; colorectal surgery; gastrointestinal tumours; infection control; microbiology; surgery.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Study process or the flow of the study. POD, postoperative day.

Similar articles

Cited by

References

    1. Young PY, Khadaroo RG. Surgical site infections. Surg Clin North Am 2014;94:1245–64. 10.1016/j.suc.2014.08.008 - DOI - PubMed
    1. Serra-Burriel M, Keys M, Campillo-Artero C, et al. . Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: systematic review and meta-analysis. PLoS One 2020;15:e0227139. 10.1371/journal.pone.0227139 - DOI - PMC - PubMed
    1. Cheadle WG. Risk factors for surgical site infection. Surg Infect 2006;7:s7–11. 10.1089/sur.2006.7.s1-7 - DOI - PubMed
    1. Liu J, Li N, Hao J, et al. . Impact of the antibiotic stewardship program on prevention and control of surgical site infection during peri-operative clean surgery. Surg Infect 2018;19:326–33. 10.1089/sur.2017.201 - DOI - PubMed
    1. Owens CD, Stoessel K. Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect 2008;70 Suppl 2:3–10. 10.1016/S0195-6701(08)60017-1 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources